These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30404059)

  • 1. Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study.
    Bao XY; Wang QN; Zhang Y; Zhang Q; Li DS; Yang WZ; Zhang ZS; Zong R; Han C; Duan L
    World Neurosurg; 2019 Feb; 122():e917-e923. PubMed ID: 30404059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, surgical treatment, and long-term outcomes of moyamoya disease in a single institution of Fujian, Southeast China: A retrospective study.
    Ding YH; Chen JY; Zheng ES; Wang ZQ; Liang RS; Shi SS; Tu XK
    Medicine (Baltimore); 2023 Oct; 102(43):e35684. PubMed ID: 37904447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.
    Sun Y; Zhou G; Feng J; Chen L; Liu G; Wang J; Wang Q; Yu J; Yang X; Yang Z; Gao P; Wang S; Zhan S
    Stroke Vasc Neurol; 2021 Dec; 6(4):615-623. PubMed ID: 33941642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nationwide survey on unilateral moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
    Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya disease in China: its clinical features and outcomes.
    Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
    Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated with Neurologic Deterioration After Combined Direct and Indirect Revascularization in Patients with Moyamoya Disease on the East Coast of China.
    Zhai X; Mao L; Wang H; Zhang X; Hang C; Wu W; Jia Y; Liu L
    World Neurosurg; 2018 Oct; 118():e92-e98. PubMed ID: 29945005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and clinical features of Moyamoya disease in Nanjing, China.
    Miao W; Zhao PL; Zhang YS; Liu HY; Chang Y; Ma J; Huang QJ; Lou ZX
    Clin Neurol Neurosurg; 2010 Apr; 112(3):199-203. PubMed ID: 20004511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
    Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
    World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
    Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ecological comparison study on the causal association between leptospirosis and moyamoya disease in Hubei, China, 2017-2019.
    Ma Z; Wang X; Li M; Zhou D; Chen J
    Clin Neurol Neurosurg; 2021 Nov; 210():107007. PubMed ID: 34741974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting diseases of moyamoya vasculopathy.
    Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of moyamoya disease in Hawaii.
    Graham JF; Matoba A
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S31-5. PubMed ID: 9409401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.